Leadership & Pay ·
William Rote, Ph.D., Chief Research Officer, announced his intention to retire on February 17, 2027
TVTXTravere Therapeutics, Inc.
William Rote, Ph.D., Chief Research Officer, announced his intention to retire on February 17, 2027. Jula Inrig, M.D., current Chief Medical Officer, will be named Executive Vice President, Head of Research & Development and Chief Medical Officer effective July 1, 2026. Travere Therapeutics, Inc. is a biotechnology company focused on developing and commercializing therapeutic solutions for rare diseases.